Examkin

Soru

Zorluk: ZorPediatric Infectious Diseases

A 10-year-old girl is evaluated in the hospital on day 3 of her admission for acute hematogenous osteomyelitis of the left proximal tibia. Upon admission, her temperature was 39.2°C (102.6°F), blood pressure was 110/70 mm Hg, and heart rate was 118/min. She had severe left leg pain, localized swelling over the proximal tibia, and an inability to bear weight. Magnetic resonance imaging of the left lower extremity demonstrated marrow edema and a small subperiosteal abscess. She was empirically started on intravenous vancomycin and ceftriaxone. Today, she is clinically improved, her pain has decreased, and she has been afebrile for the past 24 hours. Blood cultures drawn on admission are now growing Staphylococcus aureus. Susceptibility testing shows the organism is resistant to penicillin, but susceptible to oxacillin, cefazolin, clindamycin, and vancomycin. Which of the following is the most appropriate next step in this patient's pharmacotherapy?

  1. Discontinue vancomycin and ceftriaxone, and begin intravenous cefazolinCevap
  2. B
    Discontinue ceftriaxone and continue intravenous vancomycin
  3. C
    Maintain the current regimen of vancomycin and ceftriaxone
  4. D
    Discontinue vancomycin and ceftriaxone, and begin intravenous daptomycin
  5. E
    Add intravenous gentamicin to the current regimen

Cevap

The most appropriate next step is to discontinue vancomycin and ceftriaxone and begin intravenous cefazolin.
The correct answer involves discontinuing the empiric regimen of vancomycin and ceftriaxone and initiating a targeted, narrow-spectrum beta-lactam such as intravenous cefazolin. Blood cultures have confirmed methicillin-susceptible Staphylococcus aureus (MSSA). For invasive MSSA infections like osteomyelitis, beta-lactam antibiotics (e.g., cefazolin, nafcillin, oxacillin) are the definitive drugs of choice. They demonstrate superior bactericidal activity, better bone penetration, and improved clinical outcomes compared to vancomycin. Continuing vancomycin for an MSSA infection is a common pitfall that leads to suboptimal clearance of the infection and directly violates the core principles of antimicrobial stewardship.

Adım Adım Çözüm

1
Analyze the patient's diagnosis and clinical status.
The patient is a 10-year-old girl improving on empiric antibiotics for acute hematogenous osteomyelitis.
Establishing the clinical trajectory helps determine if the patient is ready for de-escalation of therapy.
2
Interpret the microbiologic culture and susceptibility data.
Blood cultures grew Staphylococcus aureus susceptible to oxacillin, cefazolin, and vancomycin. This confirms a methicillin-susceptible S. aureus (MSSA) infection.
Definitive antimicrobial therapy must be tailored to the specific pathogen and its susceptibility profile.
3
Apply principles of antimicrobial stewardship to select the best targeted therapy.
Transition the patient from empiric broad-spectrum coverage (vancomycin and ceftriaxone) to a targeted, narrow-spectrum beta-lactam (cefazolin).
Beta-lactams are superior to vancomycin for MSSA infections, providing faster bacterial clearance and improved clinical outcomes while minimizing the risk of emerging resistance.

Anahtar Kavram

Invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections, such as osteomyelitis, should be treated with narrow-spectrum beta-lactam antibiotics (e.g., cefazolin, oxacillin) rather than vancomycin, due to superior efficacy and adherence to antimicrobial stewardship.
Bu soruyu puanla

Konular

Pediatric Infectious Diseases

Bu konudan daha fazla soru